s6y

Jounce Therapeutics, Inc.

CIK
1640455
Industry
Biological Products, (No Diagnostic Substances)

Financials 26

  1. 10-K/A Annual Report for period ending Dec 31, 2022
  2. 10-K Annual Report for period ending Dec 31, 2022
  3. 10-Q Quarterly Report for period ending Sep 30, 2022
  4. 10-Q Quarterly Report for period ending Jun 30, 2022
  5. 10-Q Quarterly Report for period ending Mar 31, 2022
  6. 10-K Annual Report for period ending Dec 31, 2021
  7. 10-Q Quarterly Report for period ending Sep 30, 2021
  8. 10-Q Quarterly Report for period ending Jun 30, 2021
  9. 10-Q Quarterly Report for period ending Mar 31, 2021
  10. 10-K Annual Report for period ending Dec 31, 2020

All 26 financials filings

News 65

  1. 8-K Current report filing
  2. 8-K Current report filing
  3. 8-K Current report filing
  4. 8-K Current report filing
  5. 8-K Current report filing
  6. 8-K Current report filing
  7. 8-K Current report filing
  8. 8-K Current report filing
  9. 8-K Current report filing
  10. 8-K Current report filing

All 65 news filings

Ownership 220

  1. SC 13G/A Major Shareholders
  2. SC 13G Major Shareholders
  3. SC 13G/A Major Shareholders
  4. SC 13D/A Major Shareholders
  5. 4 Statement of changes in beneficial ownership of securities
  6. 4 Statement of changes in beneficial ownership of securities
  7. 3 Initial statement of beneficial ownership of securities
  8. 4 Statement of changes in beneficial ownership of securities
  9. 4 Statement of changes in beneficial ownership of securities
  10. 4 Statement of changes in beneficial ownership of securities

All 220 ownership filings

Prospectus 36

  1. S-8 POS Post-effective amendment to a S-8 registration statement
  2. S-8 POS Post-effective amendment to a S-8 registration statement
  3. S-8 POS Post-effective amendment to a S-8 registration statement
  4. S-8 POS Post-effective amendment to a S-8 registration statement
  5. S-8 POS Post-effective amendment to a S-8 registration statement
  6. S-8 POS Post-effective amendment to a S-8 registration statement
  7. S-8 POS Post-effective amendment to a S-8 registration statement
  8. SC TO-T/A Third party tender offer statement
  9. SC TO-T/A Third party tender offer statement
  10. SC TO-T/A Third party tender offer statement

All 36 prospectus filings

Proxies 13

  1. DEFA14A Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
  2. DEFA14A Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
  3. DEFA14A Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
  4. DEF 14A Definitive proxy statements
  5. DEFA14A Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
  6. DEF 14A Definitive proxy statements
  7. DEFA14A Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
  8. DEFA14A Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
  9. DEF 14A Definitive proxy statements
  10. DEFA14A Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.

All 13 proxies filings

Other 45

  1. 15-12G Notice of termination of registration of a class of securities under Section 12(g)
  2. EFFECT Notice of Effectiveness
  3. EFFECT Notice of Effectiveness
  4. POS AM Post-effective amendment to a registration statement that is not immediately effective upon filing
  5. POS AM Post-effective amendment to a registration statement that is not immediately effective upon filing
  6. SC 14D9/A Tender offer solicitation/recommendation statements filed under Rule 14d-9
  7. 25-NSE Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
  8. UPLOAD Letter (PDF)
  9. UPLOAD Letter (PDF)
  10. UPLOAD Letter (PDF)

All 45 other filings